01Apr April 2014 Posted by Barny Avocats, in Workflow Cabinet Barny advised Immutep on the conclusion of a manufacturing agreement by Immutep and Eddingpharm on the product ImmuFact IMP321 (a LAG-31g fusion protein) at WuXi Apptec facilities in China.